官网上说的疗效是这样的:
“In the pivotal Phase III study of NUPLAZID, we observed significant reductions in the severity and frequency of hallucinations and delusions in patients with Parkinson’s disease psychosis. Importantly, these benefits were achieved without impairing motor function.”
“在三期临床试验阶段,我们观察到了极其明显的降低了帕症病人幻觉和妄想的症状。重要的是,这些药物的效用是在不损害运动功能的前提下获得的。”